Effects of erythropoietin on the bone microenvironment

References

• Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT. 2006. Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor. Nature. 7076:599–603.
   Google Scholar
• Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P. 2002. Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 1:128–134.
   Google Scholar
• Ammarguellat F, Gogusev J, Drueke TB. 1996. Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor. Nephrol Dial Transplant (Official Publication of the European Dialysis and Transplant Association—European Renal Association). 4:687–692.
   Google Scholar
• Anagnostou A, Liu Z, Steiner M, Chin K, Lee ES, Kessimian N, Noguchi CT. 1994. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA Am. 9:3974–3978.
   Google Scholar
• Anjos-Afonso F, Bonnet D. 2007. Flexible and dynamic organization of bone marrow stromal compartment. Br J Haematol. 3:373–384.
   Google Scholar
• Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T. 2004. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell. 2:149–161.
   Google Scholar
• Asaumi Y, Kagaya Y, Takeda M, Yamaguchi N, Tada H, Ito K, Ohta J, Shiroto T, Shirato K, Minegishi N, Shimokawa H. 2007. Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice. Circulation. 15:2022–2032.
   Google Scholar
• Bab IA. 1995. Postablation bone marrow regeneration: An in vivo model to study differential regulation of bone formation and resorption. Bone. 4 Suppl: 437S–441S.
   Google Scholar
• Bab IA, Einhorn TA. 1993. Regulatory role of osteogenic growth polypeptides in bone formation and hemopoiesis. Crit Rev Eukaryot Gene Expr. 1:31–46.
   Google Scholar
• Bab I, Gazit D, Chorev M, Muhlrad A, Shteyer A, Greenberg Z, Namdar M, Kahn A. 1992. Histone H4-related osteogenic growth peptide (OGP): A novel circulating stimulator of osteoblastic activity. EMBO J. 5:1867–1873.
   Google Scholar
• Bozlar M, Kalaci A, Aslan B, Baktiroglu L, Yanat AN, Tasci A. 2006. Effects of erythropoietin on fracture healing in rats. Saudi Med J. 8:1267–1269.
   Google Scholar
• Brager MA, Patterson MJ, Connolly JF, Nevo Z. 2000. Osteogenic growth peptide normally stimulated by blood loss and marrow ablation has local and systemic effects on fracture healing in rats. J Orthop Res (Official Publication of the Orthopaedic Research Society). 1:133–139.
   Google Scholar
• Brines M, Cerami A. 2005. Emerging biological roles for erythropoietin in the nervous system. Nat Rev Neurosci. 6:484–494.
   PubMed Web of Science ®Google Scholar
• Brines M, Cerami A. 2006. Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise. Kidney Int. 2:246–250.
   Google Scholar
• Brines M, Grasso G, Fiordaliso F, Sfacteria A, Ghezzi P, Fratelli M, Latini R, Xie QW, Smart J, Su-Rick CJ, Pobre E, Diaz D, Gomez D, Hand C, Coleman T, Cerami A. 2004. Erythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptor. Proc Natl Acad Sci USA. 41:14907–14912.
   Google Scholar
• Brines M, Patel NS, Villa P, Brines C, Mennini T, De Paola M, Erbayraktar Z, Erbayraktar S, Sepodes B, Thiemermann C, Ghezzi P, Yamin M, Hand CC, Xie QW, Coleman T, Cerami A. 2008. Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc Natl Acad Sci USA. 31:10925–10930.
   Google Scholar
• Cai Z, Manalo DJ, Wei G, Rodriguez ER, Fox-Talbot K, Lu H, Zweier JL, Semenza GL. 2003. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation. 1:79–85.
   Google Scholar
• Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature. 6960:841–846.
   Google Scholar
• Calvillo L, Latini R, Kajstura J, Leri A, Anversa P, Ghezzi P, Salio M, Cerami A, Brines M. 2003. Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling. Proc Natl Acad Sci USA. 8:4802–4806.
   Google Scholar
• Cheung JY, Miller BA. 2001. Molecular mechanisms of erythropoietin signaling. Nephron. 3:215–222.
   Google Scholar
• Coleman TR, Westenfelder C, Togel FE, Yang Y, Hu Z, Swenson L, Leuvenink HG, Ploeg RJ, d'Uscio LV, Katusic ZS, Ghezzi P, Zanetti A, Kaushansky K, Fox NE, Cerami A, Brines M. 2006. Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. Proc Natl Acad Sci USA. 15:5965–5970.
   Google Scholar
• Cuzzocrea S, Mazzon E, Di Paola R, Patel NS, Genovese T, Muia C, De Sarro A, Thiemermann C. 2004. Erythropoietin reduces the development of experimental inflammatory bowel disease. J Pharmacol Exp Ther. 3:1272–1280.
   Google Scholar
• Dexter TM, Spooncer E. 1987. Growth and differentiation in the hemopoietic system. Ann Rev Cell Biol. 3:423–441.
   PubMedGoogle Scholar
• Einhorn TA. 2005. The science of fracture healing. J Orthop Trauma. 10 Suppl: S4–S6.
   Google Scholar
• Erbayraktar S, de Lanerolle N, de Lotbiniere A, Knisely JP, Erbayraktar Z, Yilmaz O, Cerami A, Coleman TR, Brines M. 2006. Carbamylated erythropoietin reduces radiosurgically-induced brain injury. Mol Med. 4–6:74–80.
   Google Scholar
• Erbayraktar S, Grasso G, Sfacteria A, Xie QW, Coleman T, Kreilgaard M, Torup L, Sager T, Erbayraktar Z, Gokmen N, Yilmaz O, Ghezzi P, Villa P, Fratelli M, Casagrande S, Leist M, Helboe L, Gerwein J, Christensen S, Geist MA, Pedersen LO, Cerami-Hand C, Wuerth JP, Cerami A, Brines M. 2003. Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci USA. 11:6741–6746.
   Google Scholar
• Fandrey J, Bunn HF. 1993. In vivo and in vitro regulation of erythropoietin mRNA: Measurement by competitive polymerase chain reaction. Blood. 3:617–623.
   Google Scholar
• Fantacci M, Bianciardi P, Caretti A, Coleman TR, Cerami A, Brines M, Samaja M. 2006. Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia. Proc Natl Acad Sci USA. 46:17531–17536.
   Google Scholar
• Farrell F, Lee A. 2004. The erythropoietin receptor and its expression in tumor cells and other tissues. The Oncologist. 9 Suppl 5: 18–30.
   PubMedGoogle Scholar
• Ferguson C, Alpern E, Miclau T, Helms JA. 1999. Does adult fracture repair recapitulate embryonic skeletal formation?. Mech Dev. 1–2:57–66.
   Google Scholar
• Foldes J, Naparstek E, Statter M, Menczel J, Bab I. 1989. Osteogenic response to marrow aspiration: Increased serum osteocalcin and alkaline phosphatase in human bone marrow donors. Jbone Miner Res (The Official Journal of the American Society for Bone and Mineral Research). 4:643–646.
   PubMed Web of Science ®Google Scholar
• Frank SJ. 2002. Receptor dimerization in GH and erythropoietin action–it takes two to tango, but how?. Endocrinology. 1:2–10.
   Google Scholar
• Garcia P, Speidel V, Scheuer C, Laschke MW, Holstein JH, Histing T, Pohlemann T, Menger MD. 2011. Low dose erythropoietin stimulates bone healing in mice. J Orthop Res (Official Publication of the Orthopaedic Research Society). 2:165–172.
   Google Scholar
• Gazit D, Karmish M, Holzman L, Bab I. 1990. Regenerating marrow induces systemic increase in osteo- and chondrogenesis. Endocrinology. 5:2607–2613.
   Google Scholar
• Greenberg Z, Chorev M, Muhlrad A, Shteyer A, Namdar-Attar M, Casap N, Tartakovsky A, Vidson M, Bab I. 1995. Structural and functional characterization of osteogenic growth peptide from human serum: Identity with rat and mouse homologs. J Clin Endocrinol Metab. 8:2330–2335.
   Google Scholar
• Gurevitch O, Khitrin S, Valitov A, Slavin S. 2007. Osteoporosis of hematologic etiology. Exp Hematol. 1:128–136.
   Google Scholar
• Gurevitch O, Prigozhina TB, Pugatsch T, Slavin S. 1999. Transplantation of allogeneic or xenogeneic bone marrow within the donor stromal microenvironment. Transplantation. 9:1362–1368.
   Google Scholar
• Haroon ZA, Amin K, Jiang X, Arcasoy MO. 2003. A novel role for erythropoietin during fibrin-induced wound-healing response. Am J Pathol. 3:993–1000.
   Google Scholar
• Holstein JH, Menger MD, Scheuer C, Meier C, Culemann U, Wirbel RJ, Garcia P, Pohlemann T. 2007. Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing. Life Sci. 10:893–900.
   Google Scholar
• Ilizarov GA, Chepelenko TA, Izotova SP, Kochetkov Iu S. 1986. Effect of acute blood loss on stromal regulation of hematopoietic stem cells and reparative bone regeneration. Patol Fiziol Eksp Ter. 5:54–58.
   PubMedGoogle Scholar
• Jelkmann W. 2004. Molecular biology of erythropoietin. Intern Med. 8:649–659.
   Google Scholar
• Lacombe C, Mayeux P. 1998. Biology of erythropoietin. Haematologica. 8:724–732.
   Google Scholar
• Lee MY, Fukunaga R, Lee TJ, Lottsfeldt JL, Nagata S. 1991. Bone modulation in sustained hematopoietic stimulation in mice. Blood. 10:2135–2141.
   Google Scholar
• Lemischka IR. 1997. Microenvironmental regulation of hematopoietic stem cells. Stem cells. 15 Suppl 1: 63–68.
   PubMedGoogle Scholar
• Li Z, Li L. 2006. Understanding hematopoietic stem-cell microenvironments. Trends Biochem Sci. 10:589–595.
   Google Scholar
• Lucas TS, Bab IA, Lian JB, Stein GS, Jazrawi L, Majeska RJ, Attar-Namdar M, Einhorn TA. 1997. Stimulation of systemic bone formation induced by experimental blood loss. Clin Orthop Relat Res. 340:267–275.
   Google Scholar
• Mennini T, De Paola M, Bigini P, Mastrotto C, Fumagalli E, Barbera S, Mengozzi M, Viviani B, Corsini E, Marinovich M, Torup L, Van Beek J, Leist M, Brines M, Cerami A, Ghezzi P. 2006. Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo. Mol Med. 7–8:153–160.
   Google Scholar
• Mihmanli A, Dolanmaz D, Avunduk MC, Erdemli E. 2009. Effects of recombinant human erythropoietin on mandibular distraction osteogenesis. J Oral Maxillof Surg (Official Journal of the American Association of Oral and Maxillofacial Surgeons). 11:2337–2343.
   Google Scholar
• Moon C, Krawczyk M, Ahn D, Ahmet I, Paik D, Lakatta EG, Talan MI. 2003. Erythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in rats. Proc Natl Acad Sci USA. 20:11612–11617.
   Google Scholar
• Moore KA, Pytowski B, Witte L, Hicklin D, Lemischka IR. 1997. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci USA. 8:4011–4016.
   Google Scholar
• Nilsson SK, Johnston HM, Whitty GA, Williams B, Webb RJ, Denhardt DT, Bertoncello I, Bendall LJ, Simmons PJ, Haylock DN. 2005. Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood. 4:1232–1239.
   Google Scholar
• Parsa CJ, Matsumoto A, Kim J, Riel RU, Pascal LS, Walton GB, Thompson RB, Petrofski JA, Annex BH, Stamler JS, Koch WJ. 2003. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest. 7:999–1007.
   Google Scholar
• Reikeras O, Wang JE, Foster SJ, Utvag SE. 2007. Staphylococcus aureus peptidoglycan impairs fracture healing: An experimental study in rats. J Orthop Res (Official Publication of the Orthopaedic Research Society). 2:262–266.
   Google Scholar
• Rose DM, Cardarelli PM, Cobb RR, Ginsberg MH. 2000. Soluble VCAM-1 binding to alpha4 integrins is cell-type specific and activation dependent and is disrupted during apoptosis in T cells. Blood. 2:602–609.
   Google Scholar
• Shiozawa Y, Jung Y, Ziegler AM, Pedersen EA, Wang J, Wang Z, Song J, Lee CH, Sud S, Pienta KJ, Krebsbach PH, Taichman RS. 2010. Erythropoietin couples hematopoiesis with bone formation. PloS one. 5:e10853.
   PubMed Web of Science ®Google Scholar
• Singbrant S, Russell MR, Jovic T, Liddicoat B, Izon DJ, Purton LE, Sims NA, Martin TJ, Sankaran VG, Walkley CR. 2011. Erythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironment. Blood. 21:5631–5642.
   Google Scholar
• Tada H, Kagaya Y, Takeda M, Ohta J, Asaumi Y, Satoh K, Ito K, Karibe A, Shirato K, Minegishi N, Shimokawa H. 2006. Endogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusion. Cardiovas Res. 3:466–477.
   Google Scholar
• Taichman RS. 2005. Blood and bone: Two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood. 7:2631–2639.
   Google Scholar
• Taichman RS, Emerson SG. 1994. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med. 5:1677–1682.
   Google Scholar
• Taichman RS, Reilly MJ, Emerson SG. 1996. Human osteoblasts support human hematopoietic progenitor cells in vitro bone marrow cultures. Blood. 2:518–524.
   Google Scholar
• Takenaka T, Itaya Y, Ishikawa I, Kobayashi K, Tsuchiya Y. 2003. Skeletal effects of erythropoietin in hemodialysis patients. Int Urol Nephrol. 3:407–413.
   Google Scholar
• Tan CC, Eckardt KU, Ratcliffe PJ. 1991. Organ distribution of erythropoietin messenger RNA in normal and uremic rats. Kidney Int. 1:69–76.
   Google Scholar
• Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D. 2004. The molecular triad OPG/RANK/RANKL: Involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 6:457–475.
   Google Scholar
• Tsai PT, Ohab JJ, Kertesz N, Groszer M, Matter C, Gao J, Liu X, Wu H, Carmichael ST. 2006. A critical role of erythropoietin receptor in neurogenesis and post-stroke recovery. J Neurosci (The Official Journal of the Society for Neuroscience). 4:1269–1274.
   Google Scholar
• Wilson A, Trumpp A. 2006. Bone-marrow haematopoietic-stem-cell niches. Nat Rev Immunol. 2:93–106.
   Google Scholar
• Wright GL, Hanlon P, Amin K, Steenbergen C, Murphy E, Arcasoy MO. 2004. Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury. FASEB J (The Official Journal of the American Society for Bone and Mineral Research). 9:1031–1033.
   Google Scholar
• Yamaguchi T, Takada Y, Maruyama K, Shimoda K, Arai Y, Nango N, Kosaki N, Takaishi H, Toyama Y, Matsuo K. 2009. Fra-1/AP-1 impairs inflammatory responses and chondrogenesis in fracture healing. J Bone Miner Res (The Official Journal of the American Society for Bone and Mineral Research). 12:2056–2065.
   Google Scholar
• Yazigi A, Maalouf G, Inati-Khoriati A, Tamim H, Saab C. 2002. Bone mineral density in beta—thalassemic Lebanese children. J Musculoskelet Neuronal Interact. 5:463–468.
   Google Scholar
• Yin T, Li L. 2006. The stem cell niches in bone. J Clin Investig. 5:1195–1201.
   Google Scholar
• Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature. 6960:836–841.
   Google Scholar
• Zhu L, Jin W, Pan H, Hu Z, Zhou J, Hang C, Shi J. 2009. Erythropoietin inhibits the increase of intestinal labile zinc and the expression of inflammatory mediators after traumatic brain injury in rats. J Trauma. 3:730–736.
   Google Scholar